Reporters and news media writers can visit our page specifically cultivated for press contacts. The page features a list of LUGPA spokespeople.

Latest News


LUGPA's COVID-19 / Coronavirus Information Hub collects all the relevant resources, announcements and recommended reading about telemedicine, practice management, and events to help you during this pandemic.

HHS Announces $20 Billion in Phase 3 Provider Relief Funding - Providers can begin applying for funds October 5, 2020
Oct. 5, 2020 
HHS has announced a new round of Provider Relief Finding that will distribute $20 billion to eligible providers. Eligible providers for this new Phase 3 include providers that have already received Provider Relief Fund payments as well as select groups of providers that were previously ineligible, such as those who began practicing in 2020. 

LUGPA applauds the unanimous passage of Veterans Prostate Cancer Treatment and Research Act
September 24, 2020 
On September 22, 2020, the House of Representatives unanimously passed the Veterans Prostate Cancer Treatment and Research Act (H.R. 6092) supported by LUGPA. The bill, sponsored by Representative Neal Dunn, MD, directs the Secretary of Veterans Affairs to establish a standardized clinical pathway for prostate cancer treatment and submit a plan that provides for continual funding for prostate cancer research through the Veterans Affairs Office of Research and Development. Additionally, the bill creates a real-time registry to track patient progress and will allow patients greater access to cutting edge clinical trials. Read more

How to Save Independent Medical Practices
September 22, 2020 
While independent medical practices face significant challenges, they are an important part of the health care market and need to be protected. In a video interview with Medical Economics, Richard Harris, M.D., president of LUGPA, an organization advocating on behalf of independent physicians, discusses telehealth, the viability and future of independent practice amid the COVID-19 pandemic, hospital consolidation and more.

Dr. Shore Discusses NEJM Studies in Video Series
August 31, 2020 
Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center and Past-President of LUGPA, has led an extensive amount of research in the treatment and management of prostate cancer. In a series of interviews with Oncology Tube, Dr. Shore talks about three recent NEJM Studies (Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer, Olaparib for Metastatic Castration-Resistant Prostate Cancer, and Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer).

Regulators delay final updates to self-referral law
August 27, 2020 
Federal regulators pushed again updates to the self-referral and anti-kickback laws to August 2021, HHS and CMS introduced Wednesday.  “The recent decision to delay final action on the Stark Law and Anti-Kickback Statute is a blow to independent physician practices across the country that see overhaul as necessary to transforming our healthcare system to one that pays for value," said LUGPA president Richard G. Harris, MD. "LUGPA and its member practices have been championing the transition from fee-for-service to value-based care models since 2015’s bipartisan passage of MACRA. As a result of this delay, we can expect that the innovation the Administration is so committed to unlocking will remain stymied until CMS finalizes the Anti-Kickback Statute (and Stark) Proposed Rules. It is unclear how yesterday’s announcement will affect the Office of Inspector General’s concurrent process, but our organization will continue to stay engaged so that the nation’s independent physicians have a champion who gives voice to them in their continued fight to expand the services patients want. It’s been proven that independent physicians offer the highest quality care at costs more reasonable than hospitals, letting them expand their offerings without fear of violating anti-kickback statutes will help the entire health care system.” A portion of Dr. Harris' quote was used in this article published in Modern Healthcare. 

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians
August 15, 2020 
Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organizations that provide a substantial and comprehensive framework, there are numerous clinical scenarios that are not always addressed, especially as new treatments become available, new imaging modalities are developed, and advances in genetic testing continue. LUGPA is pleased to announce the publication of this article in The Prostate, by Neal D. Shore, MD, et al. The 14-member expert review panel was comprised of medical oncologists and LUGPA urologists.  

Mathew Fakhoury, DO, Receives LUGPA’s 2020 Resident Clinical Innovation Award
August 13, 2020 
LUGPA announced the selection of Mathew Fakhoury, DO, as winner of the LUGPA 2020 Resident Clinical Innovation Award. In its first year, the Resident Clinical Innovation Award recognizes innovative clinical work of urology residents and fellows that promotes and has the potential to enhance quality clinical outcomes. The award acknowledges the value of clinical innovation to harness new technologies, access big data, develop systems of care to prevent, diagnose or treat urological disease and promote urological health.

New Promising Treatments for Advanced Prostate Cancer
August 5, 2020 
Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center and Past-President of LUGPA, has led an extensive amount of research in the treatment and management of prostate cancer. In an interview with Oncology Times, Shore takes a deeper dive into the research and discusses how we can save the lives of patients living with prostate cancer.

After COVID-19, LUGPA More Important Than Ever
July 31, 2020 
In the Summer 2020 issue of Reviews In Urology, Richard G. Harris, MD, president of LUGPA, writes: "In times of crisis like these, LUGPA’s efforts are more important than ever."   

Now Is Price Transparency’s Moment
July 31, 2020 
In an op-ed in Morning Consult, Richard G. Harris, MD, president of LUGPA, writes: “In recent years Americans have become familiar with the quote, “Never let a good crisis go to waste” — and for the nation’s largest hospital systems, many of which are sitting on billions of dollars of financial reserves, the challenges brought on by the coronavirus are no different. Through active lobbying of Congress and the administration, hospitals have received more than $175 billion in bailouts to date with more requested. But, in an effort to flip the script as hospitals lobby for additional funds, Congress should not let this crisis go to waste: now is the time for the federal government to push its price transparency agenda.”

Court Upholds 340B Hospitals' Medicare Part B Drug Reimbursement Cuts 
July 31, 2020 
Today, the U.S. Court of Appeals for the District of Columbia Circuit overturned a federal district judge’s ruling that CMS exceeded its statutory authority by reducing Medicare Part B drug reimbursement for 340B hospitals in 2018 and 2019. In today’s ruling, a panel of judges voted 2-1 to affirm CMS’ authority to change OPPS in order to align reimbursement for drugs acquired under the 340B program more closely to hospital costs in acquiring those drugs. 

LUGPA launches After the Storm Webinar Series
July 28, 2020 
LUGPA has launched the After the Storm Webinar Series to address key issues for independent urology practices coming out of the COVID-19 pandemic. The September 2020 webinars will highlight new and emerging treatments in a variety of conditions including prostate cancer, bladder cancer, erectile dysfunction and medical spa services.

LUGPA launches the Executive Leadership Program
July 27, 2020 
LUGPA has launched the Executive Leadership Program, a 12-month comprehensive leadership development course designed specifically for independent urology group physicians and administrators.

Appeals Court Delivers Win for HHS' Site-Neutral Payment Policy
Angie Stewart, Becker’s ASC Review 
July 20, 2020 
The U.S. Court of Appeals ruled July 17 that HHS was within its rights to reduce payments to hospital outpatient departments, reversing a district court's earlier decision. Richard Harris, MD, the president of LUGPA, an organization advocating on behalf of independent physicians, shared the following statement on the appellate court's decision: "For too long, independent physicians were forced to stand up to the consolidation and market monopolization of large healthcare systems aided by an unfair reimbursement system that paid hospital outpatient departments as much as twice for the same service as independent physicians. With today's decision, the DC Circuit has supported CMS' authority to adjust payments under the OPPS system in response to perceived reimbursement dynamics that unnecessarily increase volume of service."

Court Victory for Independent Medicine in Fight for Site-Neutral Payments 
July 17, 2020 
Today, the court has unanimously reversed a district court decision that had determined the rate change in the 2019 OPPS was outside of HHS authority. While the hospital plaintiffs may file an appeal, today’s decision is a big win for independent practices that provide services to Medicare patients to level the playing field.

Independent Practice Perspectives on COVID-19 
July 15, 2020 
At LUGPA, we hear the voices of independent practices across the country and believe you should too. Explore and watch the #IndependentPerspectives of our network of physicians and administrators as they describe on video the impact of COVID-19 on revenue, care delivery and the future of healthcare. Learn more about their experiences and challenges providing care in the midst of a global pandemic.

SRC/NAFC Center of Excellence In Continence Care for Women
July 10, 2020 
Surgical Review Corporation (SRC) and the National Association for Continence (NAFC) have collaborated to create a Center of Excellence in Continence Care for Women (COECCW) accreditation program. Center of Excellence programs recognize hospitals, ambulatory surgical centers and specific medical professionals from their service lines who are committed to achieving defined standards for patient safety and care quality. The COECCW program is focused specifically on facilities that address the needs of those with urinary incontinence, overactive bladder and pelvic organ prolapse. To begin the process of becoming a COECCW or to learn more, click here.

Pandemic Exacts Economic Toll on Urology Practices
June 25, 2020 
COVID-19 caused a huge revenue drop for urology practices nationwide, according to LUGPA President Richard G. Harris, MD, a urologist at UroPartners in the greater Chicago, Illinois, area. “What I’m hearing is most people are functioning with about 30% to 40% capability,” Harris said. Medicine’s revenue cycle tends to lag about 2 months after practices bill for services. Urologists might not have realized the full impact of the COVID-19 monetary crisis until May or into June, according to Harris. Telemedicine is slowly ramping up at UroPartners and should help pay the bills as the practice resumes in-person appointments and elective procedures, according to Harris. “In a normal month, we have between 16,000 and 18,000 evaluation and management code submissions. Right now, the telehealth code submissions are in the 3,000 to 4,000 range. That’s double what it was a month ago,” Harris said in late April. If laws remain relaxed for telehealth use, the trend for increasing utilization will continue in urology. LUGPA is lobbying for the government to keep telehealth regulations as they have been during the pandemic, according to Harris.

Asinof Retires from Urology Center of Colorado and LUGPA Board
June 18, 2020 
At the end of June, Robert D. Asinof, MHSA, retires from his CEO position at the Urology Center of Colorado. He has been the administrator of the group since 1992, and has more than 35 years of experience in the healthcare industry. He will also be retiring from the LUGPA Board at that time.

Practicing Medicine in the COVID-19 Pandemic: Doctors Adapt, Improvise
June 12, 2020 
Our president, Dr. Richard Harris, spoke with Renal & Urology News about the existing and future impact of COVID-19 on his practice. The article contains his insights as well as insights from others in the industry.  

LUGPA Leaders Published in NEJM
June 2, 2020 
LUGPA Past President Neal Shore, MD, and other LUGPA member co-authors had three trials published in the New England Journal of Medicine (NEJM) recently.

  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER trial)
  • Olaparib for Metastatic Castration-Resistant Prostate Cancer (PROfound trial)
  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (HERO trial)

More Nuanced Approach Needed to Fight COVID-19

May 29, 2020

In an op-ed in Life Science Leader , John McManus, president and founder of The McManus Groups writes: “As the data on COVID infections and deaths are tabulated, it has become clear that a more nuanced and targeted approach is needed to protect the vulnerable and allow the rest of the country to reopen and get back to work, school, and the day-to-day activities that make life enjoyable. Protecting the elderly, particularly those in nursing homes, should be the paramount public health priority, but continued and indefinite shutdowns of schools, camps, and activities of the young are not relevant to protecting the public.”

Mara R. Holton: Coronavirus Could Shut Down Independent Medical Practices Across Maryland and the Nation
May 24, 2020 
In a Capital Gazette op-ed, LUGPA Board member Mara Holton, MD writes: “What happens to patients and our healthcare system if independent physicians are unable to weather the storm and practices across the nation close? More patients will have no choice but to pay the higher costs seen within local hospital monopolies. Consolidation and care costs will continue increasing unabatedly. Protecting patients and the future of our healthcare system means protecting independent practices. Congress and insurers must step up their support or risk losing this vital part of America’s healthcare infrastructure. The implications of independent practices closing cannot be overstated as we face this crisis and consider the healthcare landscape of the future.”

How COVID-19 Imperiled Physician Practices, And How to Save Them
May 6, 2020 
RevCycle Intelligence has published an article that quotes LUGPA President, Dr. Harris several times and shares his insights and perspectives on the impact of COVID-19 on telehealth, revenue, and reimbursement for independent physicians and their practices.   

Physician groups 'struggling to survive' after COVID-19 — Will they succumb to hospital buyouts? 4 thoughts from Dr. Richard Harris
May 1, 2020 
LUGPA President Richard Harris, MD, a Melrose Park, Ill.-based urology specialist, shared his thoughts with Becker's ASC Review on how independent practices will fare — and what can be done to help them survive — after the crisis subsides.

Can Independent Practices Survive This Crisis Without Government Support? 
April 23, 2020
With in-office visits declining by 50 percent or more, many independent medical practices may need outside help to survive. Medical Economics interviewed LUGPA board member Mara R. Holton, MD, who has been active on the Health Policy and Political Affairs and LUGPA Forward committees.  

From house calls to drive-thru visits, independent physicians adapt amid COVID-19 crisis.
April 14, 2020 
LUGPA President Dr. Harris is quoted in this ABC news article regarding the COVID-19 challenges facing independent physicians. 

American Patients Vastly Prefer Healthcare Price Transparency, According to New Survey

April 3, 2020 
Medical Economics
 published an article on LUGPA's price transparency survey. The article shares the findings from the survey, and includes quotes from LUGPA President Dr. Harris. Additionally, the same article also appeared in Physicians Practice.  

New Survey Finds 91% of Americans Want Healthcare Price Transparency
April 1, 2020
LUGPA released the results of a new survey of American consumers that found an overwhelming majority of Americans support price transparency in healthcare. When surveyed, 91% of the 1,342 respondents said they believe hospitals and healthcare facilities should be required to publicly disclose the costs of their services. What’s more, 66% of respondents believe price transparency will improve healthcare.

LUGPA Leaders Convene Panel to Optimize Role of ADT in Advanced Prostate Cancer
March 23, 2020
LUGPA is pleased to announce the publication of "Optimizing the Role of Androgen Deprivation Therapy in Advanced Prostate Cancer: Challenges Beyond the Guidelines" in The Prostate (Prostate. 2020 Mar 4. doi: 10.1002/pros.23967),  Neal D. Shore, MD, et al.  Dr. Shore, Past President of LUGPA (2016-2018), led a 14- member expert panel of LUGPA and Academic urologists and medical oncologists, which discussed key questions on the use of ADT in clinical practice – addressing questions that are not always answered by prior published guidelines. 

LUGPA's Actions During the COVID-19 Crisis - Protecting Independent Urology Practice
March 20, 2020 
It is critical that we hear about the magnitude of issues you are facing now with regard to the Coronavirus, so that we can communicate this growing list to the members of Congress. It’s imperative they understand exactly what is at stake. Read more here.

Telehealth Medicare Restrictions Relaxed Due to Coronavirus
March 19, 2020 
The Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) was signed into law on March 6, 2020. It is a bipartisan bill that includes, among other provisions, waivers to certain telehealth requirements to allow Medicare patients to receive telehealth services at home.
Read more here.

LUGPA Postpones Events through April due to Coronavirus
March 2020 
NOTICE: Due to the Coronavirus Pandemic, LUGPA will postpone all LUGPA in-person events through April. These postponements include the Bladder Cancer Academy in Atlanta, the April Regional Meeting in Miami [now July 10-11] , the April Rising Chief Residents Summit in Miami [now July 10-11] and the April DC Fly-Ins. 
Read more here.

LUGPA announces new Resident Clinical Innovation Award 
March 2020 
The Resident Clinical Innovation Award recognizes and celebrates the innovative clinical work of urology residents and fellows that promotes and has the potential to enhance quality clinical outcomes. The award acknowledges the value of clinical innovation to harness new technologies, access to big data and/or the development of systems of care to prevent, diagnose or treat urological disease and promote urological health. Submit Now! 

LUGPA President Interviewed by Urology Times

LUGPA President Dr. Harris discusses legislative/policy challenges in 2020. Urology Times spoke with Dr. Harris at the 2019 LUGPA annual meeting in Chicago.

Members of Congress Need to Hear from You! 
LUGPA DC Fly-In Dates Announced for 2020

February 18, 2020 
Lawmakers are most responsive when they hear from physicians from their districts and states. That’s why we encourage your group to send a physician and/or senior administrator to Washington, DC to attend our Capitol Hill visits with the LUGPA Political Affairs Committee. 
Read more about the 2020 Fly-In dates.

LUGPA Supports Bipartisan House Bill: the PSA Screening for HIM Act
February 11, 2020 
On February 11, 2020, LUGPA sent a letter to House Representatives Bobby L. Rush and Larry Bucshon in strong support for H.R. 5200, the PSA Screening for High-risk Insured Men (HIM) Act. The letter states, "The PSA Screening for HIM Act is critically important as the number of deaths due to prostate cancer has been increasing – prostate cancer is now the second highest cancer-related cause of death in the United States. Tragically, many of these lives would not have been lost had the cancer been detected early. The goal of your legislation is laudable as it will increase access to prostate cancer screenings by eliminating cost-sharing requirements to patients."   

LUGPA Escalates its Fight for Site-Neutral Payments
February 5, 2020 
Continuing our ongoing efforts as advocates for site-neutral payments, the LUGPA Board approved the development of an amicus curiae brief in support of the HHS Secretary’s action to cap rates for hospital clinic visit services in the off-campus outpatient department setting. To read more, click here.   

Report of the Advanced Prostate Cancer Consensus Conference 2019

January 28, 2020 
Innovations in treatments, imaging, and molecular characterization in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.  To read more, click here.

Comment Letters Recently Submitted

January 1, 2020 
On December 31, 2019, LUGPA sent comment letters to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services regarding 
the Anti-Kickback Statute Proposed Rule and the Stark Proposed Rule (respectively).  To read these letters and learn more about LUGPA's stance on these issues, click here .   

LUGPA 2019 Annual Meeting Recap
December 18, 2019
From start to finish of our three-day meeting, we saw the exchange of ideas, heard valuable insights and discussed solutions to enhance, improve and grow our individual groups. To see photos from the meeting and read a recap of all the meeting highlights, click here.

AUDIO Interview: Dr. Shore Discusses the article "Preserving Independent Urology: LUGPA’s First Decade"
December 18, 2019
Neal D. Shore, MD and E. David Crawford, MD, discuss the Reviews in Urology article (excerpted and linked below) and the ways in which LUGPA has advocated on behalf of community urology physicians and patients over the last ten years.

AACU, AUA, LUGPA Join Forces on ESWL Reimbursement
December 6, 2019
Representatives from the three national urology societies — AACU, AUA and LUGPA — met with the director and other staff from the Division of Outpatient Care at the Centers for Medicare & Medicaid Services (CMS) to urge the agency to reverse a coding change that will negatively impact urologists.

Preserving Independent Urology: LUGPA’s First Decade
December 2, 2019
Recently published in Reviews in Urology, this article is an encompassing overview of LUGPA's origins and evolution over the past ten years.

Jeb Bush Discusses Politics and More at LUGPA

November 9, 2019 
A comprehensive rundown of Jeb Bush's keynote address and Q&A session at the 2019 LUGPA Annual Meeting was covered in Check it out here. More coverage of the 2019 LUGPA Annual Meeting can be found here.  

LUGPA Reappoints Three Members to Board of Directors
November 8, 2019
LUGPA announced today the reappointment of three members to the 2020 Board of Directors at the 2019 Annual Meeting held November 7-9 in Chicago.

E. Scot Davis is Elected to LUGPA Board of Directors
November 8, 2019
E. Scot Davis, CEO of Arkansas Urology, was elected to LUGPA’s Board of Directors at the 2019 Annual Meeting held on November 7-9 in Chicago. 

Urology Groups: 340B Program Reform Needed
October 18, 2019
A new study by the Partnership for Health Analytic Research (PHAR) appears to bolster arguments by independent physicians and those who operate outpatient clinics that they are at a substantial financial disadvantage against hospitals when it comes retaining profits from the administration of injectable and infused drugs. [...]

Profit Disparity Between Hospitals, Independent Practices Has 'Catastrophic Implications' — 3 Thoughts from Dr. Mara Holton
October 2, 2019
Independent practices retained 9 percent of profits from physician-administered medicines, with hospitals retaining the other 91 percent, according to the Partnership for Health Analytic Research's new Hospital Margin Analysis Report. Mara Holton, MD, discussed the findings with Becker's ASC Review. Dr. Holton is an independent physician and vice chair of the health policy committee for LUGPA, the Large Urology Group Practice Association. [...]

Overcoming Hurdles for Soon-To-Be Practitioners
The 2019 Rising Chief Resident Summit

September 26, 2019
In this video, Thomas F. Stringer, MD, FACS joins Neal Shore, MD to share highlights from his presentation at the 2019 Rising Chief Residents Summit. Dr. Stringer presented on crucial topics including vetting employment contracts, pursuing a career in academia, hospital-employed, industry employed, community, and independent practices. He also covered physician and practice agreements and what you don't know could hurt you, as well as resident training interests, future residency training, what's changed in part with resident training, the duty hour requirement, and business training.

Hospitals Retain 91% of Profit from Physician-Administered Drugs
September 17, 2019
Hospital keep a greater share of the gross profit margin on physician-administered drugs, indicating a need to level the playing field for physician practices, according to some experts. [...]

Hospitals Drive More Costs, Get Less Scrutiny
September 11, 2019
After a six-week recess (ahem, “district work period”), Congress is finally reconvening to commence work on drug-pricing legislation. A combination of populist ire over rising out-of-pocket drug costs and left-wing antipathy for for-profit healthcare has fueled legislation that would fundamentally rewrite the Medicare and Medicaid prescription drug programs. [...]

3 ASC Price Transparency Insights
September 10, 2019
Three ASC industry experts shared their insights on price transparency with Becker's ASC Review. [...]

How Benchmarking Helps Manage Your Time, Identify Problem Areas
August 22, 2019
LUGPA recently teamed with IntrinsiQ Specialty Solutions (IQSS), part of AmerisourceBergen, to support a new benchmarking program powered by InfoDive, IQSS’s business analytics solution. This collaboration, LUGPA says, will allow LUGPA member practices to compare independent group practice performance metrics against that of other member practices. [...]

How a 70-Physician Specialty Practice Centralized RCM Processes — 5 Insights 
August 07, 2019 

Maryanne Thompson is the controller for MidLantic Urology, a specialty practice with 46 locations and 70-plus physicians in the U.S. Ms. Thompson told Becker's ASC Review about MidLantic Urology's biggest revenue cycle management problem and how AI helped solve it. [...]

AAOS Will Be 'Closely Evaluating' How Trump's Executive Order Affects Orthopedics 
July 17, 2019 
In late June, President Donald Trump issued an executive order intended to lower costs and help patients make informed decisions by increasing price transparency in healthcare. The decree elicited a cautiously optimistic response from the American Association of Orthopaedic Surgeons, which provides musculoskeletal education to more than 38,000 orthopedic surgeons around the world. [...]

CMS Proposed Rule on Bundled Payment for Radiation Therapy Services
July 16, 2019
On July 10th CMS released the proposed rule regarding the bundled payment for radiation therapy services. The development of a radiation oncology APM was stipulated in the payment freeze passed by Congress; for some time LUGPA has been engaged with CMS and other stakeholders to ensure that integrated urology practices were not excluded from participation. […]

New Study Shows Americans Are Concerned About How Hospital Mergers and Acquisitions Will Impact Their Care
December 7, 2018
CHICAGO, IL, December 3, 2018 – LUGPA, today released a new national survey of 1,191 adults that revealed more than sixty percent of adult Americans are concerned about the impact of hospital mergers and acquisitions on their access to affordable care, with 25 percent reporting that this increasing trend is a threat to their health. […]

LUGPA to Testify at Stark Law Hearing in Support of Modernization
July 17, 2018
WASHINGTON, DC, July 17, 2018 – Appearing today at a hearing of the United States House of Representatives’ Ways and Means Committee entitled, “Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program,” LUGPA’s Past President and Advanced Payment Model Task Force Chair, Gary Kirsh, MD, testified on the […]

LUGPA Supports CMS’ Efforts to Modernize Stark Law
June 22, 2018
On June 20, 2018, The Centers for Medicare & Medicaid Services (CMS) issued a request for public comment on how to address the regulatory impact and burden of the physician self-referral law known as Stark Law. LUGPA issued the following statement. LUGPA commends CMS for its efforts to address the barriers created by outdated Stark […]

LUGPA statement on UPSPTF Recommendations
May 9, 2018
On May 8, the United States Preventive Services Task Force (USPSTF) posted its Prostate Cancer Screening final recommendations. LUGPA recognizes the decision by USPSTF to finalize its preliminary Grade “C” recommendation for PSA screening of men aged 55-69 is an improvement over its 2012 one-size-fits-all recommendation against PSA-based screening for any man. Yet, our […]

Proposed Certificate of Need Effort in Michigan Defeated
March 29, 2018
Urologists Mobilized to Defeat Threat to Independent Practices Chicago, IL, March 27, 2018 – In the wake of a successful coordinated effort by LUGPA and its Michigan-based member practices and in conjunction with other health care providers to defeat a proposed Certificate of Need requirement for […]

LUGPA Endorses AACU Policy Statement on Genomic Testing
March 12, 2018
Chicago, March 7, 2018—The National Comprehensive Cancer Network (NCCN) guidelines for Prostate Cancer version 1.2018, incorporate a position statement on genomic testing in prostate cancer. The position statement was proposed by the American Association of Clinical Urologists (AACU) and endorsed by LUGPA. The following statement can be […]

Budget Proposal Focuses Discussion of Physician Self-Referral Reform
February 19, 2018
New Budget Encourages Participation in APMs Chicago, IL, February 16, 2018 – Earlier this week, President Trump released a proposed budget for 2019, which included several proposals that impact independent physician practices. Two of the outlined proposals will directly impact LUGPA practices: the first proposal eliminates the […]

Healthcare Funding Addressed in Congressional Budget Resolution
February 9, 2018
LUGPA Sees Opportunity for Independent Practices Under New Healthcare Policies Chicago, IL, February 9, 2018 – Today, the United States Congress passed a major budget resolution to fund the government, which included several provisions important to health care providers. LUGPA has been a vocal champion for […]

LUGPA Supports Government’s Efforts to Modernize Stark Law
January 25, 2018
LUGPA Supports Government’s Efforts to Modernize Stark Law New Task Force Announced by Federal Government Recognizes a Glaring Need Chicago, IL, January 22, 2018–On January 17, 2018, CMS Administrator Seema Verma announced that The Centers for Medicare & Medicaid Services (CMS) will form an interagency group to review the regulatory barriers posed by Stark law. […]